Sep 30, 2012

United Therapeutics Q3 2012 Earnings Report

Total Revenue
$243M
Previous year: $202M
+20.2%
EPS
$1.46
Previous year: $1.45
+0.7%
Gross Profit
$215M
Previous year: $179M
+19.8%
Cash and Equivalents
$263M
Previous year: $344M
-23.4%
Free Cash Flow
$86.7M
Previous year: $62.8M
+38.0%
Total Assets
$1.65B
Previous year: $1.67B
-1.2%

United Therapeutics

United Therapeutics